These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25223209)

  • 1. [The anti-inflammatory effect of 0.1% bromfenac and 0.1% betamethasone combination in post-cataract surgery patients with diabetes mellitus].
    Terada Y; Masuda A; Nejima R; Maruyama Y; Miyata K
    Nippon Ganka Gakkai Zasshi; 2014 Aug; 118(8):645-51. PubMed ID: 25223209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes.
    Shimura M; Nakazawa T; Yasuda K; Nishida K
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):284-91. PubMed ID: 17593013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.
    Walter KA; Lee RY; Chen K; Komanski C
    Arq Bras Oftalmol; 2020; 83(1):55-61. PubMed ID: 31664337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
    Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
    Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
    Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L
    Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
    Song SH; Baek SK; Lee MW; Lee YH
    Korean J Ophthalmol; 2020 Feb; 34(1):46-55. PubMed ID: 32037749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
    Endo N; Kato S; Haruyama K; Shoji M; Kitano S
    Acta Ophthalmol; 2010 Dec; 88(8):896-900. PubMed ID: 19725815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.
    De Maria M; Coassin M; Mastrofilippo V; Cimino L; Iannetta D; Fontana L
    Adv Ther; 2020 Jul; 37(7):3223-3233. PubMed ID: 32440977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
    Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH
    Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery.
    Dieleman M; Wubbels RJ; van Kooten-Noordzij M; de Waard PW
    J Cataract Refract Surg; 2011 Sep; 37(9):1589-97. PubMed ID: 21855759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
    Lane SS; Holland EJ
    J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Coassin M; Iovieno A; Soldani A; Cavuto S; Cimino L; Sartori A; Formisano D; Fontana L
    J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
    Wentz SM; Price F; Harris A; Siesky B; Ciulla T
    Expert Opin Pharmacother; 2019 Oct; 20(14):1703-1709. PubMed ID: 31343372
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study.
    Flaxel C; Schain MB; Hamon SC; Francis PJ
    Retina; 2012 Mar; 32(3):417-23. PubMed ID: 21862953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
    Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Findl O; Murta JCN; Goslings WRO; Tassignon MJ; Joosse MV; Henry YP; Rulo AHF; Güell JL; Amon M; Kohnen T; Nuijts RMMA;
    J Cataract Refract Surg; 2018 Apr; 44(4):429-439. PubMed ID: 29778106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
    Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.